Antonio Araujo (António Araújo)

Scopus Author ID ResearcherID Ciência ID ORCID

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 31

Top Venues

Current oncology (Toronto, Ont.)

Cancers

Autopsy & case reports

Journal of clinical medicine

Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar

Instituto de Ciências Biomédicas Abel Salazar (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar Sep 01 2017

Portugal

Full Professor

Centro Hospitalar e Universitário do Porto Mar 15 2014

Portugal

Head of the Department :: Department of Medical Oncology

Centro Hospitalar de Entre o Douro e Vouga Oct 15 2008 - Mar 15 2014

Portugal

Head of the Department :: Department of Medical Oncology

Education History

Instituto de Ciências Biomédicas Abel Salazar Jun 01 1996 - Dec 16 2010

Portugal

PHD

Publications

João Queirós Coelho, Raquel Romão, Maria João Sousa, Sérgio Xavier Azevedo, Paula Fidalgo, Antonio Araujo
Vitiligo-like Lesions as a Predictor of Response to Immunotherapy in Non-Small Cell Lung Cancer: Comprehensive Review and Case Series from a University Center. Current oncology (Toronto, Ont.) 31 (2) (2024)
Andriani G Charpidou, Grigorios T Gerotziafas, Sanjay Popat, Antonio Araujo, Arnaud Scherpereel, Hans-Georg Kopp, Paolo Bironzo, Gilbert Massard, David Jiménez, Anna Falanga, Anastasios Kollias, Konstantinos Syrigos
Lung Cancer Related Thrombosis (LCART): Focus on Immune Checkpoint Blockade. Cancers 16 (2) (2024)
João Queirós Coelho, Raquel Romão, Maria João Sousa, Sérgio Xavier Azevedo, Paula Fidalgo, Antonio Araujo
Vitiligo-like Lesions as a Predictor of Response to Immunotherapy in Non-Small Cell Lung Cancer: Comprehensive Review and Case Series from a University Center. Current oncology (Toronto, Ont.) 31 (2) (2024)
João Queirós Coelho, Raquel Romão, Maria João Sousa, Sérgio Xavier Azevedo, Paula Fidalgo, Antonio Araujo
Vitiligo-like Lesions as a Predictor of Response to Immunotherapy in Non-Small Cell Lung Cancer: Comprehensive Review and Case Series from a University Center. Current oncology (Toronto, Ont.) 31 (2) (2024)
Urska Janzic, Natalie Maimon Rabinovich, Walid Shalata, Waleed Kian, Katarzyna Szymczak, Rafal Dziadziuszko, Marko Jakopovic, Giannis S Mountzios, Adam Płużański, Antonio Araujo, Andriani Charpidou, Sameh Daher, Abed Agbarya
Non-Small-Cell Lung Cancer Patients Harboring ROS1 Rearrangement: Real World Testing Practices, Characteristics and Treatment Patterns (ROS1REAL Study). Current oncology (Toronto, Ont.) 31 (8) (2024)
Laura Pratas Guerra, Joana Simões, Diogo Carvalho Sá, José Polónia, Antonio Araujo
Neuroendocrine breast carcinoma. Autopsy & case reports 14 (2024)
João Queirós Coelho, Raquel Romão, Maria João Sousa, Sérgio Xavier Azevedo, Paula Fidalgo, Antonio Araujo
Vitiligo-like Lesions as a Predictor of Response to Immunotherapy in Non-Small Cell Lung Cancer: Comprehensive Review and Case Series from a University Center. Current oncology (Toronto, Ont.) 31 (2) (2024)
Ana Rodrigues, Rui M Henrique, Carmen Jerónimo, Antonio Araujo
Management of typical and atypical metastatic lung carcinoids: present and future perspectives. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)
João Queirós Coelho, Raquel Romão, Maria João Sousa, Sérgio Xavier Azevedo, Paula Fidalgo, Antonio Araujo
Vitiligo-like Lesions as a Predictor of Response to Immunotherapy in Non-Small Cell Lung Cancer: Comprehensive Review and Case Series from a University Center. Current oncology (Toronto, Ont.) 31 (2) (2024)
Urska Janzic, Natalie Maimon Rabinovich, Walid Shalata, Waleed Kian, Katarzyna Szymczak, Rafal Dziadziuszko, Marko Jakopovic, Giannis S Mountzios, Adam Płużański, Antonio Araujo, Andriani Charpidou, Sameh Daher, Abed Agbarya
Non-Small-Cell Lung Cancer Patients Harboring ROS1 Rearrangement: Real World Testing Practices, Characteristics and Treatment Patterns (ROS1REAL Study). Current oncology (Toronto, Ont.) 31 (8) (2024)
Urska Janzic, Natalie Maimon Rabinovich, Walid Shalata, Waleed Kian, Katarzyna Szymczak, Rafal Dziadziuszko, Marko Jakopovic, Giannis S Mountzios, Adam Płużański, Antonio Araujo, Andriani Charpidou, Sameh Daher, Abed Agbarya
Non-Small-Cell Lung Cancer Patients Harboring ROS1 Rearrangement: Real World Testing Practices, Characteristics and Treatment Patterns (ROS1REAL Study). Current oncology (Toronto, Ont.) 31 (8) (2024)
João Queirós Coelho, Raquel Romão, Maria João Sousa, Sérgio Xavier Azevedo, Paula Fidalgo, Antonio Araujo
Vitiligo-like Lesions as a Predictor of Response to Immunotherapy in Non-Small Cell Lung Cancer: Comprehensive Review and Case Series from a University Center. Current oncology (Toronto, Ont.) 31 (2) (2024)
Laura Pratas Guerra, Joana Simões, Diogo Carvalho Sá, José Polónia, Antonio Araujo
Neuroendocrine breast carcinoma. Autopsy & case reports 14 (2024)
Andriani G Charpidou, Grigorios T Gerotziafas, Sanjay Popat, Antonio Araujo, Arnaud Scherpereel, Hans-Georg Kopp, Paolo Bironzo, Gilbert Massard, David Jiménez, Anna Falanga, Anastasios Kollias, Konstantinos Syrigos
Lung Cancer Related Thrombosis (LCART): Focus on Immune Checkpoint Blockade. Cancers 16 (2) (2024)
Antonio Araujo, Nuno Tavares, Ana Luísa Faria, Rosa Gomes, Joana Carvalho Mendonça, Bárbara Parente, Andreia Capela, Fernando Barata, Ana Macedo
Evaluation of Current Antiemetic Therapy Response in Patients Undergoing MEC or HEC Regimens in Portugal. Current oncology (Toronto, Ont.) 30 (2) (2023)
Ridhi Ranchor, Nuno Pereira, Ana R Medeiros, Manuel Magalhães, Aníbal Marinho, Antonio Araujo
Characteristics and Outcomes of COVID-19 Cancer Patients Admitted to a Portuguese Intensive Care Unit: A Case-Control Study. Cancers 15 (12) (2023)
Antonio Araujo, Nuno Tavares, Ana Luísa Faria, Rosa Gomes, Joana Carvalho Mendonça, Bárbara Parente, Andreia Capela, Fernando Barata, Ana Macedo
Evaluation of Current Antiemetic Therapy Response in Patients Undergoing MEC or HEC Regimens in Portugal. Current oncology (Toronto, Ont.) 30 (2) (2023)
Maria João Ramos, Ana Sofia Mendes, Raquel Romão, Joana Febra, Antonio Araujo
Immunotherapy in Elderly Patients-Single-Center Experience. Cancers 16 (1) (2023)
Ridhi Ranchor, Nuno Pereira, Ana R Medeiros, Manuel Magalhães, Aníbal Marinho, Antonio Araujo
Characteristics and Outcomes of COVID-19 Cancer Patients Admitted to a Portuguese Intensive Care Unit: A Case-Control Study. Cancers 15 (12) (2023)
Urska Janzic, Walid Shalata, Katarzyna Szymczak, Rafał Dziadziuszko, Marko Jakopovic, Giannis S Mountzios, Adam Płużański, Antonio Araujo, Andriani G Charpidou, Abed Agbarya
Real-World Experience in Treatment of Patients with Non-Small-Cell Lung Cancer with BRAF or cMET Exon 14 Skipping Mutations. International journal of molecular sciences 24 (16) (2023)
Raquel Romão, Ana S Mendes, Ridhi Ranchor, Maria João Ramos, João Coelho, Rita Carrilho Pichel, Sérgio Xavier Azevedo, Paula Fidalgo, Antonio Araujo
Impact of Immune-Related Adverse Events on Immune Checkpoint Inhibitors Treated Cancer Patients' Survival: Single Center Experience and Literature Review. Cancers 15 (3) (2023)
Antonio Araujo, Nuno Tavares, Ana Luísa Faria, Rosa Gomes, Joana Carvalho Mendonça, Bárbara Parente, Andreia Capela, Fernando Barata, Ana Macedo
Evaluation of Current Antiemetic Therapy Response in Patients Undergoing MEC or HEC Regimens in Portugal. Current oncology (Toronto, Ont.) 30 (2) (2023)
Antonio Araujo, Nuno Tavares, Ana Luísa Faria, Rosa Gomes, Joana Carvalho Mendonça, Bárbara Parente, Andreia Capela, Fernando Barata, Ana Macedo
Evaluation of Current Antiemetic Therapy Response in Patients Undergoing MEC or HEC Regimens in Portugal. Current oncology (Toronto, Ont.) 30 (2) (2023)
Raquel Romão, Ana S Mendes, Ridhi Ranchor, Maria João Ramos, João Coelho, Rita Carrilho Pichel, Sérgio Xavier Azevedo, Paula Fidalgo, Antonio Araujo
Impact of Immune-Related Adverse Events on Immune Checkpoint Inhibitors Treated Cancer Patients' Survival: Single Center Experience and Literature Review. Cancers 15 (3) (2023)
Maria João Ramos, Ana Sofia Mendes, Raquel Romão, Joana Febra, Antonio Araujo
Immunotherapy in Elderly Patients-Single-Center Experience. Cancers 16 (1) (2023)
Teresa Guerreiro, Alexandra Mayer, Pedro Manuel Vargues Aguiar, Antonio Araujo, Carla Nunes
The Effect of Timeliness of Care on Lung Cancer Survival - A Population-Based Approach. Annals of global health 89 (1) (2023)
Antonio Araujo, Nuno Tavares, Ana Luísa Faria, Rosa Gomes, Joana Carvalho Mendonça, Bárbara Parente, Andreia Capela, Fernando Barata, Ana Macedo
Evaluation of Current Antiemetic Therapy Response in Patients Undergoing MEC or HEC Regimens in Portugal. Current oncology (Toronto, Ont.) 30 (2) (2023)
Antonio Araujo, Nuno Tavares, Ana Luísa Faria, Rosa Gomes, Joana Carvalho Mendonça, Bárbara Parente, Andreia Capela, Fernando Barata, Ana Macedo
Evaluation of Current Antiemetic Therapy Response in Patients Undergoing MEC or HEC Regimens in Portugal. Current oncology (Toronto, Ont.) 30 (2) (2023)
Rita Carrilho Pichel, Alexandra Araújo, Vital Da Silva Domingues, Jorge Nunes Santos, Elga Freire, Ana Sofia Mendes, Raquel Romão, Antonio Araujo
Best Supportive Care of the Patient with Oesophageal Cancer. Cancers 14 (24) (2022)
Abed Agbarya, Walid Shalata, Alfredo Addeo, Andriani G Charpidou, Kristof Cuppens, Odd Terje Brustugun, Mirjana Rajer, Marco Jakopovic, Mihai Vasile Marinca, Adam Pluzanski, Thijo Jeroen N Hiltermann, Antonio Araujo
Real-World Journey of Unresectable Stage III NSCLC Patients: Current Dilemmas for Disease Staging and Treatment. Journal of clinical medicine 11 (6) (2022)
Rita Carrilho Pichel, Alexandra Araújo, Vital Da Silva Domingues, Jorge Nunes Santos, Elga Freire, Ana Sofia Mendes, Raquel Romão, Antonio Araujo
Best Supportive Care of the Patient with Oesophageal Cancer. Cancers 14 (24) (2022)

Antonio Araujo.css-eqlu8i{font-size:small;padding-left:4px;} (António Araújo)

Publication Activity (10 Years)

Top Topics

Top Venues

Antonio Araujo (António Araújo)